头孢羟氨苄结构式
|
常用名 | 头孢羟氨苄 | 英文名 | cefadroxil monohydrate |
|---|---|---|---|---|
| CAS号 | 66592-87-8 | 分子量 | 381.404 | |
| 密度 | N/A | 沸点 | 789.9ºC at 760 mmHg | |
| 分子式 | C16H19N3O6S | 熔点 | 197ºC | |
| MSDS | N/A | 闪点 | 431.5ºC |
头孢羟氨苄用途Cefadroxil hydrate (BL-S 578 hydrate) 是可口服的第一代头孢菌素,具有广谱的抗菌 (antibacterial) 活性。Cefadroxil hydrate (BL-S 578 hydrate) 为肽转运蛋白 PEPT1 和 PEPT2 的底物。 |
| 中文名 | 头孢羟氨苄 |
|---|---|
| 英文名 | cefadroxil monohydrate |
| 中文别名 | 多福霉素 | (6R,7R)-3-甲基-7-[(R)-2-氨基-2-(4-羟基苯基)乙酰氨基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-甲酸 |
| 英文别名 | 更多 |
| 描述 | Cefadroxil hydrate (BL-S 578 hydrate) 是可口服的第一代头孢菌素,具有广谱的抗菌 (antibacterial) 活性。Cefadroxil hydrate (BL-S 578 hydrate) 为肽转运蛋白 PEPT1 和 PEPT2 的底物。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
Bacterial[1][2] |
| 参考文献 |
| 沸点 | 789.9ºC at 760 mmHg |
|---|---|
| 熔点 | 197ºC |
| 分子式 | C16H19N3O6S |
| 分子量 | 381.404 |
| 闪点 | 431.5ºC |
| 精确质量 | 381.099457 |
| PSA | 167.49000 |
| LogP | 1.11530 |
| InChIKey | NBFNMSULHIODTC-CYJZLJNKSA-N |
| SMILES | CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(N)c3ccc(O)cc3)C2SC1.O |
| 外观性状 | 白色结晶固体 |
| 储存条件 | -20°C Freezer |
| 海关编码 | 2941905990 |
|---|
|
Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization.
Proc. Natl. Acad. Sci. U. S. A. 111(37) , 13313-8, (2014) Biofilm-protected microbial infections in skin are a serious health risk that remains to be adequately addressed. The lack of progress in developing effective treatment strategies is largely due to th... |
|
|
Validation of phenol red versus gravimetric method for water reabsorption correction and study of gender differences in Doluisio's absorption technique.
Eur. J. Pharm. Sci. 62 , 105-10, (2014) The aim of the present study was to develop a method for water flux reabsorption measurement in Doluisio's Perfusion Technique based on the use of phenol red as a non-absorbable marker and to validate... |
| CEFADDROXIL |
| 7-[D-(-)-a-Amino-a-(4-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic Acid Monohydrate |
| Kefroxil |
| Cephos |
| MFCD00865091 |
| Sedral |
| ULTRACEF |
| BL S 578 |
| (6R,7R)-7-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsäurehydrat |
| (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate |
| Cefradroxil |
| [6R-[6a,7b(R*)]]-7-[[Amino-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Monohydrate |
| acide (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphényl)acétyl]amino}-3-méthyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ène-2-carboxylique hydrate |
| Oracefal |
| AMOXYCILLIN |
| Cefadroxil |
| Cefa-Drops |
| Ceforal |
| Cefamox |
| p-Hydroxycephalexine Monohydrate |
| Duracef |
| 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-, hydrate (1:1) |
| Baxan |
| Bidocef |
| (6R,7R)-7-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate (1:1) |
| 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-, monohydrate |